Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager class drugs

1 result
Immunocore Commercial LLC
Usage: KIMMTRAK is indicated for HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma.